Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
90 EUR | 0.00% | -0.62% | +0.27% |
May. 21 | Sanofi Partners with Microsoft-Backed OpenAI, Formation Bio to Develop Drugs with AI | MT |
May. 21 | Sanofi: cooperation with Formation Bio and OpenAI | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.27% | 122B | |
+37.78% | 723B | |
+31.96% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+15.89% | 244B | |
+9.77% | 210B | |
-4.91% | 208B | |
+9.32% | 169B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Sanofi Exercises Option to License 4th NK Cell Engager Program in Solid Tumors From Innate Pharma's ANKET Platform